Click a link below to view the mailing archive as if it had been sent to you.
| 2019-07-31 12:15 | | Megadeals aside, pharma M&A actually dropped in the first half of 2019: report and more... |
| 2019-07-31 00:15 | | New York investigating 3 insulin makers' pricing strategies and more... |
| 2019-07-30 12:15 | | Sales gap grows between rival Merck, Bristol cancer therapies and more... |
| 2019-07-30 00:15 | | Illumina Hits a Speed Bump in the 2nd Quarter and more... |
| 2019-07-29 12:15 | | Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes and more... |
| 2019-07-29 00:15 | | The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate and more... |
| 2019-07-28 00:15 | | Pfizer in talks to merge off-patent drugs business with Mylan -source and more... |
| 2019-07-27 00:15 | | AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib and more... |
| 2019-07-26 12:15 | | Vertex's planned CEO handoff could signal stagnant growth to come: analyst and more... |
| 2019-07-26 00:15 | | Massachusetts General and ElevateBio Ink 10-Year Cell and Gene Therapy Deal and more... |
| 2019-07-25 12:15 | | Bristol-Myers’ Rosy Outlook Trumps Trial Setback as Stock Gains and more... |
| 2019-07-25 00:15 | | Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck and more... |
| 2019-07-24 12:15 | | GSK drops lung injury drugs as respiratory clear-out continues and more... |
| 2019-07-24 00:15 | | Why wait? Celgene restructures a big Jounce pact — zeroing in on new I/O pathway with $530M deal and bumping ICOS and more... |
| 2019-07-23 12:15 | | ViiV’s first-in-class HIV drug on course for filings this year and more... |
| 2019-07-23 00:15 | | Acadia drops after hours on Phase III miss for schizophrenia and more... |
| 2019-07-22 12:15 | | FDA Approves First Treatment for Oral Ulcers Associated with Rare Inflammatory Disease and more... |
| 2019-07-22 00:15 | | Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2? and more... |
| 2019-07-21 00:15 | | 100+ artificial intelligence companies to know in healthcare | 2019 and more... |
| 2019-07-20 01:07 | | CP Microbiome Report |
| 2019-07-20 00:15 | | Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market and more... |
| 2019-07-19 12:15 | | Novartis licenses out early antiviral work to Gilead and more... |
| 2019-07-19 00:15 | | Do Elon Musk’s brain-decoding implants have potential? Experts say they just might and more... |
| 2019-07-18 12:15 | | Novartis, aiming to clean up its rep, sets aside $700M for kickback settlement and more... |
| 2019-07-18 00:15 | | 87% of healthcare, pharma workers are satisfied with their jobs, survey finds and more... |
| 2019-07-17 12:15 | | Mallinckrodt Halts Midstage ALS Trial Over Safety Concerns and more... |
| 2019-07-17 00:15 | | JAMA: Withdraw This Flawed and Inaccurate Article About the 340B Program and Drug Prices and more... |
| 2019-07-16 12:15 | | J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View and more... |
| 2019-07-16 00:15 | | Why Merck is in infectious disease for the long haul and more... |
| 2019-07-15 12:15 | | AbbVie jumps into STING cancer work with Mavupharma buy and more... |
| 2019-07-15 00:15 | | 23andMe is moving into Apple’s territory with a pilot to pull in medical data, not just DNA and more... |
| 2019-07-13 12:15 | | Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY and more... |
| 2019-07-13 00:15 | | Emgality-maker Lilly courts payers with new migraine ER data and more... |
| 2019-07-12 12:15 | | Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A and more... |
| 2019-07-12 00:15 | | Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs and more... |
| 2019-07-11 12:15 | | Biosimilars Continue To Exhibit Market Failure and more... |
| 2019-07-11 00:15 | | 4 quotes from the ACA hearing and more... |
| 2019-07-10 12:15 | | Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap and more... |
| 2019-07-10 00:15 | | Bayer floats animal health merger with Lilly spinoff Elanco: report and more... |
| 2019-07-09 12:15 | | The Affordable Care Act Is Back In Court: 5 Facts You Need To Know and more... |
| 2019-07-09 00:15 | | Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019 and more... |
| 2019-07-08 12:15 | | J&J dumps Hanmi obesity drug following midphase trials and more... |
| 2019-07-08 00:15 | | Cold virus strain could be used as therapy for bladder cancer – study and more... |
| 2019-07-07 12:15 | | GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis and more... |
| 2019-07-07 00:15 | | Sangamo backs up early success for hemophilia gene therapy |
| 2019-07-06 00:15 | | French Biotech to Develop Anti-Cancer Drugs with Measles Virus and more... |
| 2019-07-03 12:15 | | Novartis struggling to win payer coverage for $2.1M gene therapy Zolgensma: analysts and more... |
| 2019-07-03 00:15 | | Edwards Lifesciences Recalls Devices After 3 Deaths Reported and more... |
| 2019-07-02 12:15 | | Vedanta Biosciences enrolls first patient in VE416 phase 1b/2 food allergy clinical study and more... |
| 2019-07-02 00:15 | | FDA Action Alert: Karyopharm, Merck and Celgene and more... |
| 2019-07-01 12:15 | | Roche closes on EU approval for Tecentriq in breast cancer and more... |
| 2019-07-01 00:15 | | Pfizer's About to Enter a Sales Slump and more... |
